摘要
目的研究影响临床免疫检验结果准确性与可靠性的质量控制相关措施。方法选取2018年1—12月本院接诊治疗的肝病患者100例,按照随机数表法将其分为研究组(采用临床免疫检验质量控制相关措施)与对照组(采用常规方法完成血液样本检测),回顾性分析两组患者中乙型肝炎肝硬化、乙型肝炎、原发性胆汁性肝硬化三种疾病的检出率。结果研究组患者乙型肝炎肝硬化、乙型肝炎、原发性胆汁性肝硬化检出率分别为100.00%、92.86%、95.83%,均高于对照组,差异均有统计学意义(P <0.05)。结论临床免疫检验质量控制相关措施可提高肝病检验结果的可靠性与准确性。
Objective To study the quality control related measures that affect the accuracy and reliability of clinical immunoassay results. Methods 100 patients were treated in our hospital from January to December 2018. They were divided into study group (using clinical immunoassay quality control related measures) and control group (using conventional methods) according to random number table method. The blood sample test was completed, the detection rate of viral hepatitis type B, HBV-related hepatic cirrhosis and primary biliary cirrhosis in the two groups was observed. Results The detection rates of viral hepatitis type B, HBV-related hepatic cirrhosis and primary biliary cirrhosis in the study group were 100.00%, 92.86% and 95.83%, respectively, which were higher than those of the control group, the difference was statistically significant (P < 0.05). Conclusion The clinical immunization quality control related measures further improve the reliability and accuracy of the test results.
作者
刘利
LIU Li(Laboratory Department,Shandong Huaheng Mining Co.,Ltd.Hospital,Xintai Shandong 271202,China)
出处
《中国卫生标准管理》
2019年第8期83-84,共2页
China Health Standard Management
关键词
临床免疫检验
质量控制
相关性措施
检验结果
可靠性
准确性
clinical immunoassay
quality control
correlation measures
test results
reliability
accuracy
